共 27 条
[1]
Andersson T., Pharmacokinetics of omeprazole in man
[2]
with special reference to single and repeated administration, drug interactions, and polymorphic metabolism, Thesis No: ISBN 91-628-0180-5
[3]
University of Goteborg, (1991)
[4]
Andersson T., Ren K., Cederberg C., Heggelund A., Rohss K., Bioavailability of omeprazole as enteric coated (EC) granules in conjunction with food on the first and seventh day of treatment, Drug Invest, 2, pp. 184-188, (1990)
[5]
Andersson T., Ren K., Cederberg C., Lagerstrom P.O., Lund- Borg P., Skanberg I., Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects, Br J Clin Pharmacol, 29, pp. 557-563, (1990)
[6]
Andersson T., Cederberg C., Edvardsson G., Heggelund A., Lundborg P., Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolisers of omeprazole, Clin Pharmacol Ther, 47, pp. 79-85, (1990)
[7]
Andersson T., Cederberg C., Regardh C.G., Skanberg I., Pharmacokinetics of different single intravenous and oral doses of omeprazole, Pur J Clin Pharmacol, 39, pp. 195-197, (1990)
[8]
Andersson T., Cederberg C., Heggelund A., Lundborg P., The pharmacokinetics of single and repeated once daily doses of 10, 20 and 40 mg omeprazole as enteric coated granules, Drug Invest, 3, pp. 45-52, (1991)
[9]
Andersson T., Regardh C.G., Dahl-Puustinen M.L., Bertilsson L., Slow omeprazole metabolisers are also poor S-mephenytoin hy- droxylators, Ther Drug Monit, 12, pp. 415-416, (1990)
[10]
Bardhan K.D., Bianchi Porro G., Bose K., Daly M., Hinchliffe R., Jonsson E., Lazzaroni M., Naesdahl J., Rikner L., Walan A., A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcer, J Clin Gastroenterol, 8, pp. 408-413, (1986)